BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27717872)

  • 1. Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.
    Patton WN; Nivison-Smith I; Bardy P; Dodds A; Ma D; Shaw PJ; Kwan J; Wilcox L; Butler A; Carter JM; Blacklock H; Szer J
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):147-152. PubMed ID: 27717872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
    Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group.
    Moore AS; Shaw PJ; Hallahan AR; Carter TL; Kilo T; Nivison-Smith I; O'Brien TA; Tapp H; Teague L; Wilson SR; Tiedemann K
    Med J Aust; 2009 Feb; 190(3):121-5. PubMed ID: 19203307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw PJ; Teague L; Fraser CJ; Carter TL; Tapp H; Alvaro F; O'Brien TA
    Pediatr Transplant; 2013 Sep; 17(6):582-8. PubMed ID: 23802616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
    Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
    Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry.
    Atkinson K; Nivison-Smith I; Hawkins T
    Aust N Z J Med; 1997 Aug; 27(4):408-19. PubMed ID: 9448882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow.
    Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds A; Hermann R; Schwarer AP; Gibson J; To LB; Arthur C;
    Bone Marrow Transplant; 2001 Jul; 28(1):21-7. PubMed ID: 11498740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.
    Nivison-Smith I; Dodds AJ; Butler J; Bradstock KF; Ma DD; Simpson JM; Szer J
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):302-8. PubMed ID: 21620988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.
    Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Ma DD; Moore JJ; Simpson JM; Szer J
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):905-12. PubMed ID: 17640594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
    Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
    Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Recipient Age and Stem Cell Source on the Association between Donor Telomere Length and Survival after Allogeneic Unrelated Hematopoietic Cell Transplantation for Severe Aplastic Anemia.
    Gadalla SM; Wang T; Dagnall C; Haagenson M; Spellman SR; Hicks B; Jones K; Katki HA; Lee SJ; Savage SA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2276-2282. PubMed ID: 27641680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.
    Cesaro S; Peffault de Latour R; Tridello G; Pillon M; Carlson K; Fagioli F; Jouet JP; Koh MB; Panizzolo IS; Kyrcz-Krzemien S; Maertens J; Rambaldi A; Strahm B; Blaise D; Maschan A; Marsh J; Dufour C;
    Br J Haematol; 2015 Nov; 171(4):606-14. PubMed ID: 26304743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
    Garderet L; Labopin M; Gorin NC; Polge E; Fouillard L; Ehninger GE; Ringden O; Finke J; Tura S; Frassoni F
    Bone Marrow Transplant; 2003 Jan; 31(1):23-9. PubMed ID: 12621503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.